Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Sep 23, 2019

Apollo Hospitals’ Pharma Business Rejig Gets Competition Commission’s Clearance

Apollo Hospitals’ Pharma Business Rejig Gets Competition Commission’s Clearance
A doctor looks at notes in a recovery unit at an Apollo Speciality Hospital, operated by Apollo Hospitals Enterprises Ltd., in the Vanagaram area of Chennai, India. (Photographer: Dhiraj Singh/Bloomberg)

The Competition Commission of India on Monday said it has approved the restructuring of Apollo Hospitals Enterprise Ltd.'s pharmacy business and its subsequent acquisition by certain investors.

Apollo Hospitals in November 2018 had announced that it would divest its front-end pharmacy business to Apollo Pharmacy for a lump sum cash consideration of Rs 527.8 crore as part of a restructuring exercise.

Following the transaction, Apollo Pharmacy Ltd. will be a wholly-owned subsidiary of Apollo Medicals Pvt. Ltd. in which Apollo Hospitals will have a 25.5 percent stake.

The other three investors in Apollo Medicals will be ENAM Securities with 44.7 percent stake, Jhelum Investment Fund 1 with 19.9 percent stake and Hemendra Kothari with 9.9 percent stake, it had said.

The CCI in a tweet on Monday said it “approves restructuring of pharmacy business of Apollo Hospitals Enterprise Limited and its subsequent acquisition by Enam Securities Private Limited, Jhelum Investment Fund I, and Hemendra Kothari”.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search